Evaluating the Use of a Concentrated Surfactant Gel in Burn Patients

Inclusion Criteria: * Subject should be an inpatient, per the Two-Midnight rule at the time of study initiation. * At the time of subject's admission in the hospital, duration of his or her burn wound should be \< or equal to 24 hours. * Subject who has a partial thickness burn wound, or an indeterminate burn wound, or who has both these characteristics in the same wound, as determined by the site Principal Investigator. * Subject's wound included in this study, does not require any surgical intervention. * Subject is able and willing to comply with requirements of this trial protocol. * Voluntarily signed informed consent obtained before any trial-related procedures are performed. * Subject must be able to communicate effectively with study personnel. * Subject has burn total body surface area (TBSA) between 1-20%. Exclusion Criteria: * Subjects with electrical or radiation burns. * Subjects who are pregnant, nursing or planning to become pregnant during the course of the study. * Subjects who have known allergies to any ingredients in the dressings used in the study. * Subjects taking opiates during the study duration. * Subjects with an active diagnosis of substance use disorder within the past six months. * Subjects with previously diagnosed issues with pain perception, including conditions such as peripheral neuropathy, if they will preclude accurate assessment of primary and secondary endpoints. * Subjects with an active infection prior to enrollment. * Subject has previous or current systemic disease(s) which, in the judgement of the investigator, is likely to interfere with treatment. Subjects with well-controlled diabetes mellitus (HbA1C\<8.5) shall be permitted.